Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Heart Journal - Cardiovascular Imaging Année : 2017

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

Pasquale Perrone-Filardi
  • Fonction : Auteur correspondant
Antonio Coca
  • Fonction : Auteur
Maurizio Galderisi
  • Fonction : Auteur
Giovanni de Simone
  • Fonction : Auteur
Thomas Kahan
  • Fonction : Auteur
Giuseppe Mancia
  • Fonction : Auteur
Josep Redon
  • Fonction : Auteur
Roland Schmieder
Bryan Williams
  • Fonction : Auteur

Résumé

Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

Dates et versions

hal-01613517 , version 1 (09-10-2017)

Identifiants

Citer

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, et al.. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients. European Heart Journal - Cardiovascular Imaging, 2017, 18 (9), pp.945-960. ⟨10.1093/ehjci/jex094⟩. ⟨hal-01613517⟩
74 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More